🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to evaluate the safety and tolerabili...
Status
Completed
Location
Research Site
Start Date
2010-06
Trial ID
NCT01156311
Treatments Being Tested
This is a 24-week phase 1b, randomized, double-blind, placebo-controlled, p...
Status
Completed
Location
Timone University Hospital, Neurology Department, UMR CRMBM CNRS 6612
Start Date
2013-04
Trial ID
NCT01808885
Treatments Being Tested
Chronic viral cardiomyopathy is a disease where the cardiac muscle is attac...
Status
Completed
Location
Multiple Locations
Start Date
2002-12
Trial ID
NCT00185250
The purpose of this trial is to evaluate the effects of Rebif® 44 mcg subcu...
Status
Completed
Location
EMD Serono, Inc.
Start Date
2010-06-30
Trial ID
NCT01085318
Treatments Being Tested
This randomized, double-blind, double-dummy, parallel-group study will eval...
Status
Completed
Location
21st Century Neurology
Start Date
2011-08-31
Trial ID
NCT01247324
Treatments Being Tested
The primary objective of this study is to determine the proportion of parti...
Status
Completed
Location
Research Site
Start Date
2013-11
Trial ID
NCT01939002
This randomized, double-blind, double-dummy, parallel-group study will eval...
Status
Completed
Location
Hope Research Institute
Start Date
2011-09-20
Trial ID
NCT01412333
Treatments Being Tested
The purpose of this study was to evaluate the improvement in spontaneous re...
Status
Terminated
Location
Ospedale Binaghi, Università di Cagliari,ASL 8
Start Date
2018-03-26
Trial ID
NCT03387046
Treatments Being Tested
The purpose of this study is to determine if the study drug is effective an...
Status
Completed
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT00370071
Treatments Being Tested
The primary objective was to evaluate the long-term safety and tolerability...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2007-10
Trial ID
NCT00811395
Treatments Being Tested